Cardiocast

What comes first with SGLT2 inhibitors – diabetes or heart failure?


 

This week in MDedge Cardiocast: Most tPA-eligible stroke patients now get treated within an hour, atrial fib patients with prior hemorrhagic stroke who get their LAA closed can be safely treated, SGLT2 inhibitors are quickly morphing from diabetes to heart failure drugs, and the MESA cardiovascular disease risk calculator can be an improvement on the ACC/AHA version.

Amazon AlexaApple Podcasts

Google Podcasts

TuneIn

Recommended Reading

Do sleep interventions prevent atrial fibrillation?
Federal Practitioner
FDA approves first spironolactone oral suspension
Federal Practitioner
Incident heart failure linked to HIV infection
Federal Practitioner
More female authors than ever in cardiology journals
Federal Practitioner
Declining lung function linked to heart failure, stroke
Federal Practitioner
PIONEER-HF called “practice changing” for acute decompensated heart failure
Federal Practitioner